Article

Join the Conversation About Oncology Nurses

Oncology nurses are on the front line of patient care, and last week, at the Oncology Nursing Society (ONS) Annual Congress, we reported on the ever-growing nursing role and recent research coming out in how they can more effectively treat patients with cancer.

Oncology nurses are on the front line of patient care, and last week, at the Oncology Nursing Society (ONS) Annual Congress, we reported on the ever-growing nursing role and recent research coming out in how they can more effectively treat patients with cancer.

Join us and our sister publication, Oncology Nursing News, for an #OncNurseConnect tweet chat on Wednesday, May 22 at 1:00 EST to discuss highlights from the conference. We want to hear about your wonderful stories with oncology nurses, as well as your patient experiences on new treatments and their side effects that were covered throughout the meeting.

To participate, follow @OncNursingNews, which will be tweeting out the questions. Once the question is asked, just join in and remember to use the #OncNurseConnect hashtag.

We hope to see you there!

Related Videos
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
Image of woman.
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Image of woman with blonde hair.
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
Related Content
Illustration of lung.
March 6th 2025

Presurgical Opdivo Plus Yervoy Has Potential Clinical Benefit in NSCLC

Alex Biese
Among patients with resectable non-small cell lung cancer, Opdivo plus Yervoy has displayed potential long-term clinical benefits versus chemotherapy.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Illustration of money.
March 6th 2025

What Patients Need to Know About Appealing Insurance Denials

Alex Biese
The CEO of Triage Cancer discussed the “best-kept secret” of the health care system in an interview with CURE.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Image of large intestines.
March 5th 2025

Thermal Ablation Noninferior to Surgery in Small-Size Colorectal Liver Metastases

Ryan Scott
Treatment with thermal ablation was noninferior to surgical resection in small-size colorectal liver metastases, according to the COLLISION trial.
Illustration of woman. Image Credit: Rachael Boer.
March 5th 2025

Organ-Sparing Treatments Bring New Life After Cancer

Sonya Collins
Avoiding surgery for rectal cancer, Sarah Rack of Memphis traveled to Houston for treatment every three weeks for 18 months.